ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1805

Effect of Short-Term Fruit Juice and Sugared Beverage Intake on Risk of Recurrent Gout Flares

Natalie McCormick1, Chio Yokose2, Minna Kohler3, Janeth Yinh1, Clara Chen4, Tuhina Neogi5, Tony Merriman6, kenneth saag7, Yuqing Zhang8 and Hyon Choi9, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Boston University School of Public Health, Boston, MA, 5Boston University School of Medicine, Boston, MA, 6University of Otago, Dunedin, New Zealand, 7University of Alabama at Birmingham, Birmingham, AL, 8Massachusetts General Hospital, Quincy, MA, 9MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA

Meeting: ACR Convergence 2022

Keywords: diet, gout, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Habitual fructose-rich beverage intake has been associated with increased serum urate (SU) levels and prevalent and incident gout. This is likely because fructose induces urate production by increasing ATP degradation to AMP. Episodic fructose-rich beverage intake may also trigger recurrent gout flares, since SU levels have been shown to increase within minutes of oral or IV fructose administration in human physiologic studies,1,2 particularly in people with gout.3 However, as mentioned in the 2020 ACR Guidelines for Gout Management, no data on fructose consumption are available for existing gout.4 We evaluated whether intake of fruit juice and other fructose-rich beverages was associated with risk for gout flares.

Methods: This case-crossover study used data collected prospectively from gout patients attending Rheumatology clinics at two US academic medical centres over 2019-2022 to evaluate risk factors for gout flares. Each participant acted as his/her own control, thus eliminating between-person differences. Participants logged on to the study website at times of gout flares and every 3 months during gout flare-free (control) periods to report on exposures, including diet and medications, during the 48 hours preceding the flare or control period.

We examined the relation of self-reported 8 oz. servings of fruit juices (orange, apple, or other) and other sugary beverages (e.g., punch, lemonade) in the prior 48 hours to the risk of gout flares using conditional logistic regression, adjusting for intake of water, sugared soda, coffee, and alcohol, and urate-lowering, diuretic, and flare prophylactic medications (NSAIDs, colchicine) during the same period.

Results: Of 862 people with gout in the study cohort, 126 had ≥ 1 gout flare during the study period and also completed ≥ 1 non-flare questionnaire (contributing a total of 157 flare periods and 317 control periods); 78% were male, mean age 58.0±17.3 years at enrollment. Higher intake of fruit juice and other sugary beverages were each associated with increased risk for gout flare (Table 1), even accounting for intake of other alcoholic and non-alcoholic beverages and medication use during the same period. Adjusted odds ratios (ORs) were 3.93 (1.47 to 10.47) for ≥3 servings of fruit juice (ref=0 servings), 3.64 (1.20 to 11.08) for ≥3 servings of other sugared beverages, and 3.07 (1.31 to 7.19) for ≥3 servings of either juice or other sugared beverages. Sugared soda consumption was uncommon (fewest number of relevant analytic pairs among beverages of interest in this cohort to date), limiting power for analyses as a flare trigger.

Conclusion: The study findings suggest that intake of fruit juices and other sugared beverages (e.g., punch, lemonade, sports drinks, sugared iced tea) both increased the risk of gout flares, in a dose-response manner. These findings could provide guidance to clinicians and patients about avoidance of high-fructose beverage consumption for prevention of both incident gout and gout flares.

References:
1. Dalbeth (2013) PMID 23349133
2. Fox (1972) PMID 5047915
3. Stirpe Lancet (1970) PMID 4098798
4. Fitzgerald (2020) PMID 32391934

Supporting image 1

Table 1. Association of Fruit Juice and Other Sugared Beverage Intake with Risk for Gout Flares


Disclosures: N. McCormick, None; C. Yokose, None; M. Kohler, Setpoint Medical, Springer; J. Yinh, None; C. Chen, None; T. Neogi, Novartis, Pfizer/Lilly, Regeneron; T. Merriman, None; k. saag, Horizon Therapeutics, SOBI, Shanton, AbbVie/Abbott; Y. Zhang, ChemoCentryx; H. Choi, Horizon, Allena, LG, Protalix.

To cite this abstract in AMA style:

McCormick N, Yokose C, Kohler M, Yinh J, Chen C, Neogi T, Merriman T, saag k, Zhang Y, Choi H. Effect of Short-Term Fruit Juice and Sugared Beverage Intake on Risk of Recurrent Gout Flares [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/effect-of-short-term-fruit-juice-and-sugared-beverage-intake-on-risk-of-recurrent-gout-flares/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-short-term-fruit-juice-and-sugared-beverage-intake-on-risk-of-recurrent-gout-flares/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology